Urinary Biomarkers and Progression of AKI in Patients with Cirrhosis | Zendy

Justin M. Belcher | Zendy; Guadalupe García–Tsao | Zendy; Arun J. Sanyal | Zendy; Heather ThiessenPhilbrook | Zendy; Aldo J. Peixoto | Zendy; Mark A. Perazella | Zendy; Naheed Ansari | Zendy; Joseph K. Lim | Zendy; Steven G. Coca | Zendy; Chirag R. Parikh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Urinary Biomarkers and Progression of AKI in Patients with Cirrhosis

Author(s) -

Justin M. Belcher,

Guadalupe García–Tsao,

Arun J. Sanyal,

Heather ThiessenPhilbrook,

Aldo J. Peixoto,

Mark A. Perazella,

Naheed Ansari,

Joseph K. Lim,

Steven G. Coca,

Chirag R. Parikh

Publication year - 2014

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.09430913

Subject(s) - medicine , acute kidney injury , albuminuria , cirrhosis , gastroenterology , lipocalin , creatinine , urinary system , kidney disease

AKI is a common and severe complication in patients with cirrhosis. AKI progression was previously shown to correlate with in-hospital mortality. Therefore, accurately predicting which patients are at highest risk for AKI progression may allow more rapid and targeted treatment. Urinary biomarkers of structural kidney injury associate with AKI progression and mortality in multiple settings of AKI but their prognostic performance in patients with liver cirrhosis is not well known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research